D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Best Scientists D-index 177 Citations 138,622 1,480 World Ranking 475 National Ranking 319
Medicine D-index 177 Citations 137,250 1,433 World Ranking 217 National Ranking 145

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His scientific interests lie mostly in Quality of life, Internal medicine, Cancer, Physical therapy and Clinical trial. His work in Quality of life tackles topics such as Psychometrics which are related to areas like Item response theory, Computerized adaptive testing, Activities of daily living and Family medicine. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Oncology.

His work focuses on many connections between Surgery and other disciplines, such as Renal cell carcinoma, that overlap with his field of interest in Sorafenib. The Cancer study combines topics in areas such as Gynecologic oncology, MEDLINE, Distress, Anemia and Ambulatory. David Cella combines subjects such as Psychological intervention, Cancer-related fatigue, Disease, Cancer therapy and Severity of illness with his study of Physical therapy.

His most cited work include:

  • The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. (4248 citations)
  • Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer (2578 citations)
  • Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer (2578 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Quality of life, Physical therapy, Cancer and Oncology. His study ties his expertise on Surgery together with the subject of Internal medicine. David Cella works mostly in the field of Quality of life, limiting it down to concerns involving Psychometrics and, occasionally, Item response theory.

His biological study deals with issues like Quality of life, which deal with fields such as Intensive care medicine and Family medicine. His Cancer research is multidisciplinary, incorporating perspectives in Lung cancer, Anemia and Gerontology. His Oncology research integrates issues from Prostate cancer and Chemotherapy.

He most often published in these fields:

  • Internal medicine (37.77%)
  • Quality of life (33.18%)
  • Physical therapy (24.59%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (37.77%)
  • Quality of life (33.18%)
  • Oncology (20.61%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Quality of life, Oncology, Clinical psychology and Physical therapy. His study in the field of Cancer, Clinical trial, Breast cancer and Lower urinary tract symptoms is also linked to topics like In patient. Cancer is closely attributed to Quality of life in his study.

His Quality of life research incorporates themes from Psychological intervention, Randomized controlled trial, Cronbach's alpha, Disease and Pediatrics. His work in Clinical psychology tackles topics such as Item response theory which are related to areas like Metric. His work in Physical therapy covers topics such as Ventricular assist device which are related to areas like Implant.

Between 2017 and 2021, his most popular works were:

  • Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer (198 citations)
  • Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial. (77 citations)
  • Lessons From the Testosterone Trials (65 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His main research concerns Internal medicine, Quality of life, Clinical psychology, Oncology and Clinical trial. As part of his studies on Internal medicine, he often connects relevant areas like Placebo. His studies deal with areas such as Psychometrics, Cross-sectional study, Cronbach's alpha, Disease and Atopic dermatitis as well as Quality of life.

His biological study spans a wide range of topics, including Patient-Reported Outcomes Measurement Information System, Item response theory, Differential item functioning, Convergent validity and Discriminant validity. His research on Patient-Reported Outcomes Measurement Information System also deals with topics like

  • Sleep disorder which is related to area like Physical therapy and Cognition,
  • Quality of life, which have a strong connection to Health related quality of life and Research design. His Oncology research includes themes of Nivolumab and Immunotherapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

D F Cella;D S Tulsky;G Gray;B Sarafian.
Journal of Clinical Oncology (1993)

6311 Citations

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy Miller;Molin Wang;Julie Gralow;Maura Dickler.
The New England Journal of Medicine (2007)

3627 Citations

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial

Mark G. Kris;Ronald B. Natale;Roy S. Herbst;Thomas J. Lynch.
JAMA (2003)

3331 Citations

The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008

David Cella;William Riley;Arthur Stone;Nan Rothrock.
Journal of Clinical Epidemiology (2010)

3107 Citations

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

Robert H. Dworkin;Dennis C. Turk;Kathleen W. Wyrwich;Dorcas Beaton.
The Journal of Pain (2008)

2753 Citations

The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.

David Cella;Susan Yount;Susan Yount;Nan Rothrock;Richard Gershon;Richard Gershon.
Medical Care (2007)

2344 Citations

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Brian I. Rini;Bernard Escudier;Piotr Tomczak;Andrey Kaprin.
The Lancet (2011)

1966 Citations

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

Suzanne B. Yellen;David F. Cella;Kimberly Webster;Carol Blendowski.
Journal of Pain and Symptom Management (1997)

1839 Citations

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves.
The New England Journal of Medicine (2013)

1825 Citations

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

Dennis A. Revicki;Ron D. Hays;David Cella;Jeff A. Sloan.
Journal of Clinical Epidemiology (2008)

1813 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Cella

Jeff A. Sloan

Jeff A. Sloan

Mayo Clinic

Publications: 164

Bryce B. Reeve

Bryce B. Reeve

Duke University

Publications: 135

Brian I. Rini

Brian I. Rini

Vanderbilt University Medical Center

Publications: 133

Bernard Escudier

Bernard Escudier

Institut Gustave Roussy

Publications: 130

Neil K. Aaronson

Neil K. Aaronson

Antoni van Leeuwenhoek Hospital

Publications: 128

Kurt Kroenke

Kurt Kroenke

Indiana University

Publications: 122

Ron D. Hays

Ron D. Hays

University of California, Los Angeles

Publications: 122

Kerry S. Courneya

Kerry S. Courneya

University of Alberta

Publications: 120

Robert J. Motzer

Robert J. Motzer

Memorial Sloan Kettering Cancer Center

Publications: 120

Phyllis Butow

Phyllis Butow

University of Sydney

Publications: 118

Toni K. Choueiri

Toni K. Choueiri

Harvard University

Publications: 117

Charles S. Cleeland

Charles S. Cleeland

The University of Texas MD Anderson Cancer Center

Publications: 117

David S. Tulsky

David S. Tulsky

University of Delaware

Publications: 114

Patricia A. Ganz

Patricia A. Ganz

University of California, Los Angeles

Publications: 113

Mark P. Jensen

Mark P. Jensen

University of Washington

Publications: 100

Allen W. Heinemann

Allen W. Heinemann

Northwestern University

Publications: 99

Trending Scientists

Per-Anders Edin

Per-Anders Edin

Uppsala University

Jaume Miret

Jaume Miret

Universitat Politècnica de Catalunya

Gilles Notton

Gilles Notton

University of Corsica Pascal Paoli

John E. Pearson

John E. Pearson

Argonne National Laboratory

Colin Collins

Colin Collins

University of British Columbia

David A. Keith

David A. Keith

University of New South Wales

Jeffrey J. Volenec

Jeffrey J. Volenec

Purdue University West Lafayette

Trina A. Schroer

Trina A. Schroer

Johns Hopkins University

Matti Korppi

Matti Korppi

Tampere University

Janusz Pempkowiak

Janusz Pempkowiak

Polish Academy of Sciences

Lingjiang Li

Lingjiang Li

Central South University

Ming Ming Chiu

Ming Ming Chiu

University of Hong Kong

Emily B. Falk

Emily B. Falk

University of Pennsylvania

Robert F. Corwyn

Robert F. Corwyn

University of Arkansas at Little Rock

Simon Borg

Simon Borg

Western Norway University of Applied Sciences

Nancy A. Madden

Nancy A. Madden

Johns Hopkins University

Something went wrong. Please try again later.